Skip to main content

Table 2 Anticancer drugs handled by APOTECAchemo

From: Performance evaluation of the compounding robot, APOTECAchemo, for injectable anticancer drugs in a Japanese hospital

Ingredient Content (mg) Ingredient Content (mg)
Amrubicin Hydrochloride 20, 50 Ifosfamide 1000
Bendamustine Hydrochloride 100 Irinotecan Hydrochloride Hydrate 40, 100
Bevacizumab
(Genetical Recombination)
100, 400 L-Asparaginase 5000 U
Carboplatin 50, 150, 450 Methotrexate 50, 200, 1000
Cetuximab
(Genetical Recombination)
100 Oxaliplatin 50, 100, 200
Cisplatin 10, 25, 50 Paclitaxel 30, 100
Cyclophosphamide Hydrate 100, 500 nab-Paclitaxel (abraxane) 100
Cytarabine 1000 Panitumumab
(Genetical Recombination)
100
Dacarbazine 100 Pemetrexed Sodium Hydrate 100, 500
Daunorubicin Hydrochloride 20 Pertuzumab
(Genetical Recombination)
420
Docetaxel 20, 80 Pirarubicin 10, 20
Doxorubicin Hydrochloride 10, 50 Ramucirumab 100
Doxorubicin Hydrochloride 20 Rituximab
(Genetical Recombination)
100, 500
Epirubicin Hydrochloride 10, 50 Temozolomide 100
Etoposide 100 Trastuzumab
(Genetical Recombination)
150
Fluorouracil 250, 1000 Vincristine Sulfate 1
Gemcitabine Hydrochloride 200, 1000 Vinorelbine Ditartrate 10, 40